Abstract
Hypertension is common in the elderly with estimates of around 10–20% showing a sustained level of pressure, either systolic (@#@ ⩾160 mmHg), or diastolic (@#@ ⩾90 mmHg) or both. The benefits of treating subjects with raised diastolic pressure was shown by the trials of the European Working Party on High Blood Pressure in the Elderly (EWPHE), the Hypertension in Elderly Patients in Primary Care (HEP), and the Swedish Trial in Old patients with Hypertension (STOP- Hypertension). Evidence for the benefit of treating isolated systolic hypertension in the elderly was provided in one trial (SHEP: Systolic Hypertension in the Elderly Program), and the results of two others are awaited. However, it is important to provide data on all treatment effects, including adverse reactions as well as benefits. In addition to traditional measures of mortality, morbidity and side effects, the quality of life in patients on antihypertensive treatment should be considered. The methods of measuring quality of life in trials is discussed, and some results presented. (Aging Clin. Exp. Res. 4: 115- 123, 1992)
Similar content being viewed by others
References
Bulpitt C.J.: Definition, prevalence and incidence of hypertension in the elderly. In: Amery A., Staessen J. (Eds.), Handbook of Hypertension. Hypertension in the Elderly, Vol. 12. Elsevier, Amsterdam, 1989, pp. 153–169.
McMahon S., Peto R., Cutler J., Collins R., Sorlie P., Neaton J., Abbott R., Godwin J., Dyer A., Stamber J.: Blood pressure, stroke and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335: 765–774, 1990.
Harris T., Cook E.F., Kännel W.B., Goldman L.: Proportional hazards analysis of risk factors for coronary heart disease in individuals aged 65 or older. The Framingham Heart Study. J. Am. Geriatr. Soc. 36: 1023–1028, 1988.
Colandrea M.A., Friedman G.D., Nichaman M.Z., Lynd C.N.: Systolic hypertension in the elderly: an epidemiologic assessment. Circulation 41: 239–245, 1970.
Kannel W.B., Dawber T.R., McGee D.L.: Perspectives on systolic hypertension: the Framingham Study. Circulation 61: 1179–1182, 1980.
Forette F., De La Fuente X., Golmard J.L., Henry J.F., Hervy M.P.: The prognostic significance of isolated systolic hypertension in the elderly: results of a ten year longitudinal survey. Clin. Exp. Hypertens. 4: 1177–1191, 1982.
Rutan G.H., Kuller L.H., Neaton J.D., Wentworth D.N., McDonald R.H., McFate Smith W.: Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial. Circulation 77: 504–514, 1988.
Garland C., Barrett-Connor E., Suarez L., Criqui M.H.: Isolated systolic hypertension and mortality after age 60 years: a prospective population-based study. Am. J. Epidemiol. 118: 365–376, 1983.
SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 265: 3255–3264, 1991.
Amery A., Birkenhäger W., Bulpitt C.J., Clément D., De Leeuw P., Dollery CT., Fagard R., Fletcher A., Forette F., Leonetti G., O’Brien E.T., O’Malley K., Rodicio J.L., Rosenfeld J., Staessen J., Strasser T., Terzoli L., Thijs L., Tuomilehto J., Webster J.: Syst-Eur. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: Objectives, protocol and organization. Aging Clin. Exp. Res. 3: 287–302, 1991.
Staessen J., Fagard R., Amery A.: Isolated systolic hypertension in the elderly: implications of SHEP for clinical practice and for the ongoing trials. J. Hum. Hypertens. 5: 469–474, 1991.
Aronow W.S., Herzig A.H., Etienne F., D’Alba P., Ronquillo J.: 41-month follow-up of risk factors correlated with new coronary events in 708 elderly patients. JAGS 37: 501–506, 1989.
Mattila K., Haavisto M., Rajala S., Heikinheimo R.: Blood pressure and five year survival in the very old. Br. Med. J. 296: 887–889, 1988.
Coope J., Warrender T.S., McPherson K.: The prognostic significance of blood pressure in the elderly. J. Hum. Hypertens. 2: 79–88, 1988.
Amery A., Birkenhäger W., Brixko P., Bulpitt C, Clément D., Deruyttere M., De Schaepdryver A., Dollery C., Fagard R., Forette F., Forte J., Hamdy R., Henry JF, Joossens J.V., Leonetti G., Lund-Johansen P., O’Malley K., Petrie J.C., Strasser T., Tuomilehto J., Williams B.: Mortality and morbidity results from the European working party on high blood pressure in the elderly trial. Lancet I: 1349–1354, 1985.
Coope J., Warrender T.S.: Randomised trial of treatment of hypertension in elderly patients in primary care. Br. Med. J. 293: 1145–1151, 1986.
Dahlof B., Lindholm L.H., Hansson L., Schersten B., Ekbom T., Wester P-O.: Morbidity and mortality in the Swedish trial in old patients with hypertension. Lancet 338: 1281–1285, 1991.
Collins R., Peto R., McMahon S., Herbert P., Riebach N.H., Gerbein K.A., Godwin J., Quizilbash N., Taylor J.O., Hennekens C.H.: Blood pressure, stroke and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 335: 827–838, 1990.
Staessen J., Van Hoof R., Fagard R., Amery A.: Epidemiology of treated and untreated hypertension in the elderly. In: Amery A., Staessen J. (Eds.), Handbook of Hypertension. Hypertension in the Elderly, Vol. 12. Elsevier, Amsterdam, 1989, pp. 320–351.
Medical Research Council Working Party: MRC trial of treatment of mild hypertension: principal results. Br. Med. J. 291: 97–104, 1985.
Fletcher A.E., Amery A., Birkenhäger W. Bulpitt C., Clément D., De Leeuw P., Deruytter M., De Schaepdryver A., Dollery C., Fagard R., Lund-Johansen P., Nissinen A., O’Brien E., O’Malley K., Pelemans W., Petrie J.C., Staessen J., Strasser T., Terzoli L., Thijs L., Tuomilehto J., Webster J., Williams B.O.: Risks and benefits in the trial of the European Working Party on High Blood Pressure in the Elderly. J. Hypertens. 9: 225–230, 1991.
Gurland B.J., Teresi J., McFate Smith W., Black D., Hughes G., Edlavitch S.: Effects of Treatment for Isolated Systolic Hypertension on Cognitive Status and Depression in the Elderly. J. Am. Geriatr. Soc. 36: 1015–1022, 1988.
Gurland B.J., Golden R.R., Teresi J., Challop J.: The SHORT-CARE: an efficient instrument for the assessment of depression, dementia and disability. J. Gerontol. 39: 166–169, 1984.
Wechsler D.: The measurement and appraisal of adult intelligence scale. Psychological corporation, New York, 1955.
Reitan R.M.: Validity of the trail making test as an indicator of organic brain damage. Percept. Mot. Skills 8: 271–276, 1958.
Schultz N.R., Dineen J.T., Elias M.F., Pentz C.A., Gibson Wood W.: WAIS performance for different age groups of hypertensive and control subjects during the administration of a diuretic. J. Gerontol. 34: 246–253, 1979.
Medical Research Council Working Party on Mild to Moderate Hypertension: Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Lancet II: 539–543, 1981.
Wassertheil-Smoller S., Blaufox D., Oberman A., Davis B.R., Swencionis C, Knerr M.O., Hawkins C.M., Langford H.G.: Effect of antihypertensives on sexual function and quality of life. The TAIM Study. Ann. Intern. Med. 114: 613–620, 1991.
Cartwright A., Smith C.: Elderly people, their medicines, and their doctors. Routledge, London & New York, 1988.
Croog S.H., Levine S., Testa M.A.: The Effects of Antihypertensive Therapy on the Quality of Life. N. Engl. J. Med. 314: 1657–1664, 1986.
Fletcher A., Chester P.C., Hawkins C.M.A., Latham A.N., Pike L.A., Bulpitt C.J.: The effects of verapamil and propranolol on quality of life in hypertension. J. Human Hypertens. 3: 125–130, 1989.
Fletcher A.E., Bulpitt C.J., Hawkins C.M.: Quality of life on antihypertensive therapy: a randomised double blind controlled trial of captopril and atenolol. J Hypertens. 8: 463–466, 1990.
Werning C., Weitz T., Ludwig B.: Assessment of Indapamide in Elderly Hypertensive Patients with Special Emphasis on Well-Being. Am. J. Med. 84 (Suppl. 1B): 104–108, 1988.
Mossey J.M., Shapiro E.: Self-rated health: a predictor of mortality among the elderly. Am. J. Public Health 72: 800–808, 1982.
Kaplan G.A., Camacho T.: Perceived health and mortality: a nine year follow-up of the human population laboratory cohort. Am. J. Epidemiol. 117: 292–304, 1983.
Grand A., Grosclaude P., Bocquet H., Pous J., Albardee J.L.: Disability, psychosocial factors and mortality among the elderly in a rural French population. J. Clin. Epidemiol. 43: 773–782, 1990.
Bulpitt C.J., Dollery C.T., Carne S.: A symptom questionnaire for hypertensive patients. J. Chronic Dis. 27: 309–323, 1974.
Bulpitt C.J., Dollery C.T., Came S.: Change in symptoms of hypertensive patients after referral to hospital clinic. Br. Heart J. 38: 121–128, 1976.
Bergner M., Bobbit R.A., Carter W.B. Gilson B.S.: The Sickness Impact Profile: development and final revision of a health status measurement. Med. Care 19: 787–805, 1981.
Fanshel S., Bush J.W.: A health status index and its application to health services out-come. Oper. Res. 18: 1021–1066, 1970.
Bulpitt C.J.: Quality of life in hypertensive patients. In: Amery A., Fagard R., Lijnen P., Staessen J. (Eds.), Hypertensive Cardiovascular Disease: Pathophysiology and Treatment. The Hague, Martinus Nijhoff, 1982, pp. 929–948.
Kellner R., Sheffield B.F.: A self-rating scale of distress. Psychol. Med. 3: 88–100, 1976.
McNair D.N.L., Lorr M., Doppleman L.F.: Manual for the profile of mood states. San Diego Educational and Industrial Testing Service, 1971.
Battersby C., Hartley K., Fletcher A.E., Markowe H.L.J., Brown R.G., Styles W., Sapper H., Bulpitt C.J.: Cognitive function and quality of life in hypertension — a community based study. Clin. Sci. 76: S16, 1989 (Abstract).
Fava G.A., Kellner R., Munari F., Pavan L.: The Hamilton Depression Rating Scale in normals and depressives. Acta Psychiatr. Scand. 66: 26–32, 1982.
Robin A., Curry S.H., Whelpton R.: Clinical and biochemical comparison of clorazepate and diazepam. Psychol. Med. 4: 388–392, 1974.
Bland J.M., Altman D.G.: Statistical methods for assessing agreement between two methods of clinical measurement. Lancet I: 307–310, 1986.
Chinn S., Burney P.G.: On measuring repeatability of data from self-administered questionnaires. Int. J. Epidemiol. 16: 121–127, 1987.
Bulpitt C.J., Hoffbrand B.I., Dollery C.T.: Contribution of drug treatment to symptoms of hypertensive patients. In: Gross F., Strasser T. (Eds.), Mild Hypertension: Natural History and Management. Pitman Medical, Bath, 1979, pp.291–302.
Kellner R., Rada R.T., Anderson T., Pathak D.: The effects of chlordiazepoxide on self-rated depression, anxiety and well-being. Psychopharmacology 64: 185–191, 1979.
Bulpitt C.J., Fletcher A.E.: The measurement of quality of life in hypertensive patients: a practical approach. Br. J. Clin. Pharmacol. 30: 353–364, 1990.
Fletcher A., McLoone P., Bulpitt C.: Quality of life on angina therapy — a randomised controlled trial of transdermal nitroglycerine against placebo. Lancet II: 4–8, 1988.
Canadian Erythropoietin Study Group: Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Br. Med. J. 300: 573–578, 1990.
Abrahams J.P., Wallach H.F., Divens S.: Behavioural improvement in long-term geriatric patients during an age-integrated psychosocial rehabilitation program. JAGS 27: 218–221, 1979.
Yeo G., Ingram L., Skurnick J., Crapo L.: Effects of a geriatric clinic on functional health and well-being of elders. J. Gerontol. 42: 252–258, 1987.
Pitt B., Adshead F., Day Codey D.: BASDEC A novel screening instrument for depression in elderly medical in-patients. Br. Med. J. (in press).
Fletcher A.: Cost effectiveness analyses in the treatment of high blood pressure. Report of the World Hypertension League on the economics of hypertension control, Barcelona, September 27–28 1991. J. Human Hypertens. (in press).
Fletcher A.: Pressure to treat and pressure to cost: a review of cost effectiveness analysis. Editorial Review. J. Hypertens. 9: 193–198, 1991.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fletcher, A., Bulpitt, C. Quality of life and antihypertensive drugs in the elderly. Aging Clin Exp Res 4, 115–123 (1992). https://doi.org/10.1007/BF03324077
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03324077